Activation of A2A ARs is crucial in cancer cells, as it promotes proliferation through the stimulation of PLC, protein kinase C delta (PKC-δ), ERK, JNK, and protein kinase B (AKT) pathways [102,103]. Here, PRKCD is linked to cancer.